Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Hemagglutinin Antigen of Influenza A Virus Subtype H3N2 (HA (H3N2))
- Target
- HA (H3N2)
- Molecular classification
- Viral protein, Glycoprotein, Lectin, Membrane protein
01
Overview
Hemagglutinin (HA) is a major surface glycoprotein and antigen of the Influenza A virus, specifically the H3N2 subtype. It mediates viral attachment to host cells via sialic acid binding and facilitates membrane fusion for viral entry. HA is a homotrimeric protein composed of HA1 and HA2 subunits, and undergoes continuous antigenic drift, making it a primary target for neutralizing antibodies and a key component of seasonal influenza vaccines. Recombinant forms are used in serological assays and vaccine development, updated annually to reflect circulating strains.
- Other names
- H3N2 HemagglutininHA protein (H3N2)Influenza A H3N2 Hemagglutinin
02
Mechanism of action
Neutralization via antibody binding to prevent viral entry
03
Biological functions
Viral attachment to host cellsMembrane fusionReceptor binding (sialic acid)Antigen presentationImmune response elicitation
04
Disease associations
Influenza A infectionRespiratory illnessPandemic (historical)Seasonal influenza
05
Safety considerations
Antigenic drift leading to vaccine mismatchPotential for reassortment with other influenza strainsImmunogenicity varies between strains and individuals
06
Biomarkers
Antibody titers against HA (H3N2)HA sequence variants for strain identification
Beyond the preview
Go deeper on Hemagglutinin Antigen of Influenza A Virus Subtype H3N2 (HA (H3N2)).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Hemagglutinin Antigen of Influenza A Virus Subtype H3N2 (HA (H3N2)).